Acid Reflux
GERD patients with persistent cough benefit from the standard daily dose of lansoprazole
Published in Health and Medicine Week, March 13th, 2006
Investigators in Italy conducted a study "to compare two different daily doses of lansoprazole given for 12 weeks and to assess the role of gastrointestinal (GI) investigations as criteria for selecting patients.
F. Baldi and colleagues from S’Orsola-Malpighi Hospital wrote, "Out of 45 patients referred for unexplained chronic persistent cough, 36 had at least one of the GI investigations (endoscopy, 24-h esophageal pH-metry and a 4-week trial of proton pump inhibitor (PPI) therapy) positive and were randomly assigned to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Allergy & Immunology
Survey shows Europeans' allergy symptoms are most severe in the morning - Diet & Nutrition
Dairy foods may assist in the management of obesity and overweight - Epidemiology
Latino field laborers not eating what they grow - Information Technology
New learning resources to help providers adopt health information technology - Accreditation
Health Management Corp. receives disease management accreditation - Addiction Medicine
Addictive behaviors may involve mechanisms of synaptic plasticity within specific amygdala circuits - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
